SKIBSTED RUSSELL Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$15,854.40
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of SKIBSTED RUSSELL

According to the SEC Form 4 filings, SKIBSTED RUSSELL, being in a position of

  1. Chief Financial Officer at Processa Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 16705 shares for $41,674, and sold 0 shares,
    over all time since 2026-03-31, has bought 16705 shares for $41,674, and sold 0 shares.

Biography of SKIBSTED RUSSELL

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $41,6747100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-06-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
3,277
0.1454%
$1.93$6,325+5.99%
2026-06-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
2,654
0.1177%
$2.22$5,892-8.37%
2026-05-29PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
2,292
0.1016%
$2.57$5,890-19.92%
2026-05-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
1,984
0.0879%
$2.97$5,892-30.07%
2026-04-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
2,190
0.0981%
$2.69$5,891-22.22%
2026-04-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
1,984
0.0879%
$2.97$5,892-28.04%
2026-03-31PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Financial Officer
2,324
0.103%
$2.54$5,891-15.02%
2017-08-23PurchaseEterna Therapeutics Inc.
ERNA
Chief Financial Officer
2,000
0.0242%
$2.64$5,285-29.77%
2017-08-23PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
4,000
0.0035%
$2.64$10,570-5.32%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.